One apparent difference from previous studies is that all tumor-infiltrating transferred CD8+ T cells in this study are specifically tumor-reactive with the same TCR clonal type while the sequenced tumor-infiltrating CD8+ T cells from patients are heterogeneous including both tumor-reactive ones and bystanders. Here, CD8A is linked to neoplasm.